4. A clinical trial compares the new drug described in Question 3 to aspirin. The group using the new drug had somewhat fewer heart attacks than those in the aspirin group. a) The p-value from the hypothesis test was 0.28. What do you conclude? b) What would you have concluded if the p-value had been 0.004